Cancer Research UK Cambridge Centre

“Brain cancers like glioblastoma are notoriously difficult to treat. I am excited to co-lead this world-first trial designed with this cancer type in mind." Dr Richard Mair, one of our Brain Cancer Virtual Institute leads, co-leads this pioneering UK-wide trial alongside Dr Juanita Lopez from The Institute of Cancer Research. The trial has been awarded over £3m, by Cancer Research UK (CRUK) and the Minderoo Foundation, to test new treatments for people living with brain cancer. Find out more ➡️ https://lnkd.in/eFx7G-Fq

Many congratulations to Prof Antonis Antoniou, affiliate of our Early Cancer Institute, University of Cambridge, on being awarded the 2024 Don Listwin Award for his work on developing breast and ovarian cancer risk prediction models.

Last the month the Cambridge Experimental Cancer Medicine Centre hosted ‘Experimental Cancer Medicine Demystified’. The popular annual event for patients, carers and anyone with an interest in cancer research took place on 27 September at the Cambridge Biomedical Campus. Around 50 people attended in-person, with others joining online to hear about our work in patient and public involvement (PPI), early detection, breast cancer, pancreatic cancer and urological malignancies.   Liz Chipchase, Cambridge ECMC PPI group lead representative, talked in the first session about different ways patients and the public can get involved in their research. The patient focus continued throughout the rest of the event, with each session featuring a patient who spoke about their experience taking part in clinical trials. Experimental Cancer Medicine Centres Network (ECMC)

The Cancer Research UK Children's Brain Tumour Centre are seeking to recruit a highly motivated Postdoctoral Transition Fellow in Machine Learning and Cancer to join Professor Richard Gilbertson's group at the Cancer Research UK Cambridge Institute. Apply by the 17 November ➡️ https://lnkd.in/eqpYjuvp The Institute of Cancer Research University of Cambridge Cancer Research UK Science and Innovation

This morning BBC Radio 4’s Today programme highlighted Cancer Research UK (CRUK)'s £173m investment in the Cancer Research UK Cambridge Institute and some of the world-leading research that is being done in Cambridge. University of Cambridge Cambridge University Hospitals NHS Foundation Trust #ChangingTheStoryOfCancer 📻 Listen back https://lnkd.in/e4dKyi7U (starts 2:41)

Radiotherapy is one of the possible treatments that might be given following a Breast Cancer diagnosis. In this interview Poppy Howe, Advanced Clinical Practitioner in Breast Radiotherapy at Cambridge University Hospitals NHS Foundation Trust, explains why radiotherapy research is important and what trials she is currently working on. #PBCI_BreastCancerAwareness

Congratulations to Prof Raj Jena on being appointed the UK's first Clinical Professor of AI in Radiotherapy. On how AI will transform the fight against cancer, he said, "We'll have more early detection programmes, and instead of having to wait for a cancer to be big enough to see on a scan, we’ll be asking can we instead analyse breath, or a finger prick of blood?” Read the full interview and watch Prof Jena explain how AI has already sped up cancer treatment: https://lnkd.in/eAVUZv3S Cambridge University Hospitals NHS Foundation Trust Cancer Research UK (CRUK) // #ChangingTheStoryOfCancer #CambridgeUniversity #CambridgeExpert

You can catch our Director and Cambridge Cancer Research Hospital Research Lead, Professor Richard Gilbertson, speaking live on a special cancer-focused BBC Look East programme this evening at 6.30pm talking about our research and the new Cambridge Cancer Research Hospital. ➡️ Read about the new cellular therapy laboratory, featuring our Cancer Immunology Co-Lead, Dr Ben Uttenthal: https://lnkd.in/ep9buQJB ➡️ Read about the expansion of the Personalised Breast Cancer Programme, featuring our Precision Breast Cancer Institute Lead, Professor Jean Abraham: https://lnkd.in/eW9_ifG7 #BBCLookEastCancerSpecial Cambridge University Hospitals NHS Foundation Trust Cancer Research UK (CRUK) University of Cambridge

We are delighted that our affiliated institute, Cancer Research UK Cambridge Institute, will benefit from this investment from Cancer Research UK (CRUK).

Join our Pancreatic Cancer Programme on #WorldPancreaticCancerDay in November for a special webinar on cancer-associated cachexia (wasting syndrome). Featuring leading researchers, we’ll dive into groundbreaking research and practical tips for managing cachexia in pancreatic cancer patients. Thursday 21 November  1.15-2pm This is a free online event is open to everyone—patients, families, researchers, and anyone interested! ✍️ Register now: https://zurl.co/ZaeB